New Combinations in the Treatment of Lung Cancer

This publication has 16 references indexed in Scilit:

• Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
  Journal of Clinical Oncology, 1998
• Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
  Journal of Clinical Oncology, 1998
• Treatment of NSCLC with chemotherapy is controversial because of low response and high cost
  Lung Cancer, 1997
• 26 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 3. Results of a randomised trial evaluating palliation & quality of life
  Lung Cancer, 1997
• Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer
  Annals of Oncology, 1997
• Revisions in the International System for Staging Lung Cancer
  Chest, 1997
• Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.
  Journal of Clinical Oncology, 1997
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer
  British Journal of Cancer, 1995
• Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.
  Journal of Clinical Oncology, 1990